Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 14 D · 4 R cosponsors

HB 2770 — An Act amending the act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, in public assistance, providing for drug cost transparency and pharmacy purchasing protections.

Last action — Referred to HEALTH, Sept. 14, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced September 14, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

In plain language

The bill requires pharmacies and distributors to report drug costs and prohibits certain rebate practices.

This bill aims to enhance transparency in drug acquisition costs for pharmacies enrolled in the Medical Assistance Program. It mandates reporting drug costs and prevents certain types of rebates from distributors to pharmacies.

What this means for you
  • Workers: If you work in a pharmacy, this bill may affect how your pharmacy handles drug pricing and reporting.

Summary

Acquisition costs in the Medical Assistance Program

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill adds new provisions regarding drug cost transparency and pharmacy purchasing protections to the Human Services Code.

  • Section 449.3

    Drug Cost Transparency and Pharmacy Purchasing Protections.--(a) Each pharmacy enrolled in the medical assistance program and each distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program shall submit to the department, in accordance with subsection (b), drug cost transparency reports related to drugs dispensed and distributed under the medical assistance program for the following purposes: (1) Identifying factors that impact pharmacy drug acquisition cost. (2) Improving transparency in the drug supply chain. (3) Understanding geographic differences in drug acquisition costs across this Commonwealth. (4) Enabling the department to analyze and make informed policy decisions. (5) Protecting pharmacies from distributor practices that disadvantage pharmacies. (b) A drug cost transparency report under subsection (a) shall be submitted in a manner, format and at a frequency as determined by the department, but no less than quarterly. The department shall determine the scope of drugs to be included in a report, the required drug and pricing data, including rebates and other discounts, and the method by which the report shall be submitted. (c) The following prohibitions shall apply to drugs distributed under the medical assistance program: (1) A distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program may not: (i) Tie the purchase price of a brand name drug to the purchase volume of generic drugs. (ii) Offer, grant or apply any off-invoice rebate or allowance to an enrolled pharmacy for purchased drugs. (2) A pharmacy enrolled in the medical assistance program may not accept or receive from a distributor any off-invoice rebate or allowance for purchased drugs. (d) As used in this section, the following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise: "Discounts" means price reductions applied at the time of purchase, including volume purchasing, prompt pay and group purchasing. "Distributor" shall have the same meaning as defined in section 2 of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act. "Off-invoice rebate or allowance" means any reduction, deduction, subtraction or discount applied by a distributor directly to the gross billing amount on the face of the actual purchase invoice. "Rebate" means the percentage of payment returned after the purchase.

    This section establishes new requirements for drug cost transparency reporting and sets prohibitions against certain rebate practices in pharmacies participating in the medical assistance program.

Action History

  1. Referred to HEALTH, Sept. 14, 2026

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 17 co-sponsors · 235 not signed on

Sponsors (1)

Co-sponsors (17)

Not signed on (235)

235 members have not signed on to this bill.

Show all 235 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2770 do?
Acquisition costs in the Medical Assistance Program
Who sponsors HB 2770?
HB 2770 is sponsored by Jessica Benham (Democratic), Kathy L. Rapp (Republican), Dan Frankel (Democratic), John C. Inglis III (Democratic), Eddie Day Pashinski (Democratic), Lisa A. Borowski (Democratic), Benjamin V. Sanchez (Democratic), Mandy Steele (Democratic), David H. Zimmerman (Republican), Brad Roae (Republican), Lindsay Powell (Democratic), Kristine C. Howard (Democratic), Daniel J. Deasy (Democratic), Tarik Khan (Democratic), Dan K. Williams (Democratic), Arvind Venkat (Democratic), Ben Waxman (Democratic), and Charity Grimm Krupa (Republican).
What is the current status of HB 2770?
This bill is in committee in the House. Introduced September 14, 2026. It must pass committee before a floor vote.
Where can I track HB 2770?
Track HB 2770 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2770

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2770

Last checked for changes 20 days ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →